Please provide your email address to receive an email when new articles are posted on . Researchers identified no link between vaginal estrogen tablet use and recurrent stroke risk. The findings did ...

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

A total of 3353 recurrent cases were identified from a cohort of 56,642 women with a first-time stroke and were matched with 3353 controls. HealthDay News — For women with a history of ischemic stroke ...

In Danish women with a history of ischemic stroke, use of vaginal estradiol tablets was not associated with an increased rate of recurrent ischemic stroke. Results suggest these women may not be so ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

Lo Loestrin Fe (norethindrone acetate/ethinyl estradiol/ferrous fumarate) is a prescription drug that’s used to prevent pregnancy. The drug comes as an oral tablet. It’s usually taken once per day. Lo ...

Add Yahoo as a preferred source to see more of our stories on Google. As our bodies undergo hormonal shifts during perimenopause and beyond, symptoms like hot flashes, sleep troubles and mood swings ...

Femlyv is the first ODT formulation approved for the prevention of pregnancy. The Food and Drug Administration (FDA) has approved Femlyv (norethindrone acetate and ethinyl estradiol), a combined oral ...

Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...